Respiration-associated modulation of cardiac contractility force
By using an implantable cardiac device to detect respiratory parameters and set the timing and intensity of cardiac contractility modulation stimulation, the problems of pain and discomfort in cardiac contractility modulation therapy are solved. Precise synchronization between cardiac contractility modulation and respiratory cycle is achieved, improving treatment efficacy and patient comfort.
Patent Information
- Application Number
- CN202080101268.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2020-03-29
- Filing Date
- 2020-10-22
- Publication Date
- 2026-07-10
- Estimated Expiration
- 2040-10-22
AI Technical Summary
Existing technologies struggle to effectively integrate cardiac contractility regulation with respiratory phases or conditions, leading to patient pain and discomfort. Furthermore, the parameter settings for cardiac contractility regulation therapy are not precise enough.
By using an implanted cardiac device, sensors can detect respiratory parameters such as respiratory rate, inhalation and exhalation time, and the timing and intensity of cardiac contractility modulation stimulation can be set to ensure that stimulation is applied during the absolute refractory period of the cardiac cycle and when the diaphragm or phrenic nerve is furthest from the heart, thus reducing pain.
It achieves precise synchronization between cardiac contractility regulation stimulation and respiratory cycle, reducing patient pain and improving the effectiveness of cardiac contractility regulation therapy and patient comfort.